Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The UNIVERSITY OF TARTU currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners and 2 distinct art units, indicating that the university's active patent applications are being reviewed in separate technical silos. This distribution is common for academic institutions whose research often spans different specialized fields of biotechnology.
KAPUSHOC, STEPHEN THOMAS is the busiest examiner for the university, with 1 pending office action under review. This represents 1 of the 2 total pending office actions for the institution. Because the portfolio is split between 2 distinct art units, the university may face different examination speeds and requirements for each application. Practitioners should be prepared to tailor their arguments to the specific technical standards of each unit, as the 2 distinct examiners will likely have different perspectives on the pharmaceutical or biological innovations at issue.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
| BAUSCH, SARAE L | 1 | 29.7% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18022000 | METHOD OF PROGNOSING PREECLAMPSIA | KAPUSHOC, STEPHEN THOMAS | — |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | BAUSCH, SARAE L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18022000 | METHOD OF PROGNOSING PREECLAMPSIA | KAPUSHOC, STEPHEN THOMAS | — |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | BAUSCH, SARAE L | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18022000 | METHOD OF PROGNOSING PREECLAMPSIA | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§112 | Final Rejection | — | Pending | Feb 17, 2023 |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | BAUSCH, SARAE L | 1699 | §101§102§112 | Final Rejection | — | Pending | Mar 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITY OF TARTU has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Stephen Thomas Kapushoc has the most, with 1 of UNIVERSITY OF TARTU's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
